Adults on CSII Treatment vs Paediatric Patients on CSII Treatment: Number of Patients With Glycated Hemoglobin on Target
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.23 | 0.219 | 0.241 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.434 | 0.404 | 0.465 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | -0.204 | -0.236 | -0.172 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 0.53 | 0.487 | 0.577 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 0.389 | 0.339 | 0.447 | log | ClinicalTrials.gov | |
| Number needed to treat, for one fewer participant with the outcome on Adults on CSII Treatment than on Paediatric Patients on CSII Treatment | 4.9 | 4.23 | 5.81 | from the risk difference interval | ClinicalTrials.gov |
Groups 2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Adults on CSII Treatment | Patients who received CSII treatment in Italy ( = or \> 18 YEARS OLD) | 1,288 | 5,598 | OG000 | ClinicalTrials.gov |
| Group 2 | Paediatric Patients on CSII Treatment | Patients \< 18 years old ON CSII treatment | 445 | 1,025 | OG001 | ClinicalTrials.gov |
Outcome 5
| Field | Value | Source |
|---|---|---|
| Type | PRIMARY | ClinicalTrials.gov |
| Title | Number of Patients With Glycated Hemoglobin on Target | ClinicalTrials.gov |
| Description | number of patients who achieved HbA1c target (\< 7,5% in patients \< 18 years old; \<7% in adult patients); | ClinicalTrials.gov |
| Time frame | 1 year | ClinicalTrials.gov |
| Population | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Continuos Subcutaneous Insulin Infusion in Italy | ClinicalTrials.gov |
| NCT number | NCT02620917 | ClinicalTrials.gov |
| Phases | ClinicalTrials.gov | |
| Conditions | Type 1 Diabetes | ClinicalTrials.gov |
| Interventions | ClinicalTrials.gov | |
| Lead sponsor | University of Padova | ClinicalTrials.gov |
| Results first posted | 2020-04-08 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT02620917?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.